The Journal of Immunology, Vol 155, Issue 9 4339-4346, Copyright © 1995 by American Association of Immunologists

ARTICLES

Presentation of endogenous peptide/MHC class I complexes is profoundly influenced by specific C-terminal flanking residues

N Shastri, T Serwold and F Gonzalez
Department of Molecular and Cell Biology, University of California, Berkeley 94720-3200, USA.

Processing of intracellular proteins yields 8-11 residue peptides that are displayed on the APC surface as peptide/MHC class I complexes. The remarkably precise excision of antigenic peptides from their precursor polypeptides raises the question of whether specific flanking residues influence presentation efficiency. Here we addressed this question by analyzing the generation of OVA/Kb or influenza nucleoprotein/Db complexes in APC expressing precursors with varying N- or C-terminal flanking residues. We find that T cell responses were not significantly affected by varying the N-terminal flanking residue in the precursors. In contrast, presentation of peptide/MHC complexes was inhibited with the addition of a single C-terminal flanking residue. The most dramatic inhibition was observed with isoleucine, leucine, cysteine, and proline as the C-terminal flanking residues. These residue-specific variations in presentation activity could not be accounted for by differences in the stimulatory activity of corresponding synthetic peptides but were proportional to the relative amounts of naturally processed peptides recovered in the cell extracts. These findings suggest differences in the susceptibility of N- vs C-terminal flanking residues to proteolytic cleavage during Ag processing. The strong influence of specific C- terminal flanking residue(s) could be an important factor affecting the choice of peptides presented to T cells on the APC surface.

This article has been cited by other articles:

				N. Tiwari, N. Garbi, T. Reinheckel, G. Moldenhauer, G. J. Hammerling, and F. Momburg A Transporter Associated with Antigen-Processing Independent Vacuolar Pathway for the MHC Class I-Mediated Presentation of Endogenous Transmembrane Proteins J. Immunol., June 15, 2007; 178(12): 7932 - 7942. [Abstract] [Full Text] [PDF]

				D. Bruder, A. K. Nussbaum, D. M. Gakamsky, M. Schirle, S. Stevanovic, H. Singh-Jasuja, A. Darji, T. Chakraborty, H. Schild, I. Pecht, et al. Multiple synergizing factors contribute to the strength of the CD8+ T cell response against listeriolysin O Int. Immunol., January 1, 2006; 18(1): 89 - 100. [Abstract] [Full Text] [PDF]

				R. Draenert, S. Le Gall, K. J. Pfafferott, A. J. Leslie, P. Chetty, C. Brander, E. C. Holmes, S.-C. Chang, M. E. Feeney, M. M. Addo, et al. Immune Selection for Altered Antigen Processing Leads to Cytotoxic T Lymphocyte Escape in Chronic HIV-1 Infection J. Exp. Med., April 5, 2004; 199(7): 905 - 915. [Abstract] [Full Text] [PDF]

				A. Boissonnas, O. Bonduelle, A. Antzack, Y.-C. Lone, C. Gache, P. Debre, B. Autran, and B. Combadiere In Vivo Priming Of HIV-Specific CTLs Determines Selective Cross-Reactive Immune Responses Against Poorly Immunogenic HIV-Natural Variants J. Immunol., October 1, 2002; 169(7): 3694 - 3699. [Abstract] [Full Text] [PDF]

				V. Novitsky, H. Cao, N. Rybak, P. Gilbert, M. F. McLane, S. Gaolekwe, T. Peter, I. Thior, T. Ndung'u, R. Marlink, et al. Magnitude and Frequency of Cytotoxic T-Lymphocyte Responses: Identification of Immunodominant Regions of Human Immunodeficiency Virus Type 1 Subtype C J. Virol., September 11, 2002; 76(20): 10155 - 10168. [Abstract] [Full Text] [PDF]

				Y.-Z. Wu, J.-P. Zhao, Y. Wan, Z.-C. Jia, W. Zhou, J. Bian, B. Ni, L.-Y. Zou, and Y. Tang Mimovirus: a Novel Form of Vaccine That Induces Hepatitis B Virus-Specific Cytotoxic T-Lymphocyte Responses In Vivo J. Virol., September 11, 2002; 76(20): 10264 - 10269. [Abstract] [Full Text] [PDF]

				M. C. Wolkers, M. Toebes, M. Okabe, J. B. A. G. Haanen, and T. N. M. Schumacher Optimizing the Efficacy of Epitope-Directed DNA Vaccination J. Immunol., May 15, 2002; 168(10): 4998 - 5004. [Abstract] [Full Text] [PDF]

				C. J. Luckey, J. A. Marto, M. Partridge, E. Hall, F. M. White, J. D. Lippolis, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Differences in the Expression of Human Class I MHC Alleles and Their Associated Peptides in the Presence of Proteasome Inhibitors J. Immunol., August 1, 2001; 167(3): 1212 - 1221. [Abstract] [Full Text] [PDF]

				A. Moreau-Aubry, S. Le Guiner, N. Labarriere, M.-C. Gesnel, F. Jotereau, and R. Breathnach A Processed Pseudogene Codes for a New Antigen Recognized by a CD8+ T Cell Clone on Melanoma J. Exp. Med., May 1, 2000; 191(9): 1617 - 1624. [Abstract] [Full Text] [PDF]

				A. X. Y. Mo, S. F. L. van Lelyveld, A. Craiu, and K. L. Rock Sequences That Flank Subdominant and Cryptic Epitopes Influence the Proteolytic Generation of MHC Class I-Presented Peptides J. Immunol., April 15, 2000; 164(8): 4003 - 4010. [Abstract] [Full Text] [PDF]

				S. Ben-Shahar, A. Komlosh, E. Nadav, I. Shaked, T. Ziv, A. Admon, G. N. DeMartino, and Y. Reiss 26 S Proteasome-mediated Production of an Authentic Major Histocompatibility Class I-restricted Epitope from an Intact Protein Substrate J. Biol. Chem., July 30, 1999; 274(31): 21963 - 21972. [Abstract] [Full Text] [PDF]

				T. Serwold and N. Shastri Specific Proteolytic Cleavages Limit the Diversity of the Pool of Peptides Available to MHC Class I Molecules in Living Cells J. Immunol., April 15, 1999; 162(8): 4712 - 4719. [Abstract] [Full Text] [PDF]

				L. M. Mylin Context-Dependent Immunogenicity of an S206G-Substituted H-2Db-Restricted Simian Virus 40 Large T Antigen Epitope I Variant J. Immunol., February 15, 1999; 162(4): 2171 - 2179. [Abstract] [Full Text] [PDF]

				M. Theobald, T. Ruppert, U. Kuckelkorn, J. Hernandez, A. Haussler, E. A. Ferreira, U. Liewer, J. Biggs, A. J. Levine, C. Huber, et al. The Sequence Alteration Associated with a Mutational Hotspot in p53 Protects Cells From Lysis by Cytotoxic T Lymphocytes Specific for a Flanking Peptide Epitope J. Exp. Med., September 21, 1998; 188(6): 1017 - 1028. [Abstract] [Full Text] [PDF]

				M. Mata, P. J. Travers, Q. Liu, F. R. Frankel, and Y. Paterson The MHC Class I-Restricted Immune Response to HIV-gag in BALB/c Mice Selects a Single Epitope That Does Not Have a Predictable MHC-Binding Motif and Binds to Kd Through Interactions Between a Glutamine at P3 and Pocket D J. Immunol., September 15, 1998; 161(6): 2985 - 2993. [Abstract] [Full Text] [PDF]

				I. Miconnet, C. Servis, J.-C. Cerottini, P. Romero, and F. Levy Amino Acid Identity and/or Position Determines the Proteasomal Cleavage of the HLA-A*0201-restricted Peptide Tumor Antigen MAGE-3271-279 J. Biol. Chem., August 25, 2000; 275(35): 26892 - 26897. [Abstract] [Full Text] [PDF]